With over 28 years of professional experience as an economist, Dr. Alexandrakis has acquired a combined managerial, research, public policy and strategy analysis background, with an extensive applied business experience in the public and private sectors. With a career that is marked by diversification and rapid escalation to positions of significant responsibility and authority, he has addressed various issues from both the perspective of the public and private sector.
The health sector though has captured an important part of his activity and today he is Adjunct Professor and Senior Research Fellow at the Athens University of Economics and Business and active in Health Sector Strategy consulting and research. Before joining the Pharmaceutical Company MSD in 2012 (known as Merck & Co., Inc. in the USA and Canada) in order to lead the Policy, Communications and Corporate Social Responsibility (CSR) activities in Greece and Cyprus, he had served as a Senior Advisor at the Hellenic Parliament, with a key responsibility on the Economic Adjustment Program of Greece and issues related to fiscal policies and legislation. Before that, for several years, he served at high-level government positions and Committees in Greece and the EU (Special State Secretary of the Greek Government, CEO of the healthcare organization of the State organization for seamen, co-ordination of PPP and Investment Committees, consultation with the Government on behalf of the Pharmacists' Association etc.).
Dr. Alexandrakis also has an extensive University level teaching and research background and has extensively worked with the EU Institutions, Industry Associations and many Government bodies. Today he is on the Research Staff of the Laboratory of Health Economics & Management of the University of Piraeus and during the past few years he has been an active member of several Committees and work-groups of SFEE (the Hellenic Pharmaceutical Industry Association), of the Hellenic-American Chamber of Commerce and the Pharma Innovation Forum.